Reviva Pharmaceuticals Holdings (RVPH) Other Accumulated Expenses (2022 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Other Accumulated Expenses of $247,174 for Q2 2026, down 73.2% from $922,592 a year earlier and down 65.6% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Reviva Pharmaceuticals Holdings' Other Accumulated Expenses came in at $791,611, up 58.1% from FY2024.
- Annual Other Accumulated Expenses has increased for three consecutive years, with a three-year compound annual growth rate of 38.4% (FY2022 to FY2025).
- In prior years, Reviva Pharmaceuticals Holdings' Other Accumulated Expenses was $500,616 in FY2024 (+25.0%), $400,490 in FY2023 (+34.1%) and $298,699 in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Other Accumulated Expenses in data going back to Q4 2022.
- On a year-over-year basis, Other Accumulated Expenses increased in six of the last seven quarters, with growth averaging 34.4%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2025, with growth of 107.2%; the weakest was Q2 2026, with a decline of 73.2%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $718,407 (Q1 2026), $791,611 (Q4 2025) and $630,471 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 6.56 Mn | 6.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 247,174.00 |
| Mar 31, 2026 | 718,407.00 |
| Dec 31, 2025 | 791,611.00 |
| Sep 30, 2025 | 630,471.00 |
| Jun 30, 2025 | 922,592.00 |
| Mar 31, 2025 | 482,864.00 |
| Dec 31, 2024 | 500,616.00 |
| Sep 30, 2024 | 428,801.00 |
| Jun 30, 2024 | 445,371.00 |
| Mar 31, 2024 | 377,367.00 |
| Dec 31, 2023 | 400,490.00 |
| Dec 31, 2022 | 298,699.00 |
API Access
Reviva Pharmaceuticals Holdings Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();